COLL vs SPGI · P/E 17, rev $181.9M vs P/E 27, rev $15.34B
Collegium Pharmaceutical Inc (COLL) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the COLL and SPGI stock pages for the full models.
Not investment advice.